- Home
- YHGJ vs NEPH Comparison
YHGJ vs NEPH Comparison
Compare YHGJ & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- NEPH
- Stock Information
- Founded
- YHGJ 1975
- NEPH 1997
- Country
- YHGJ United States
- NEPH United States
- Employees
- YHGJ N/A
- NEPH N/A
- Industry
- YHGJ Specialty Chemicals
- NEPH Medical/Dental Instruments
- Sector
- YHGJ Industrials
- NEPH Health Care
- Exchange
- YHGJ Nasdaq
- NEPH Nasdaq
- Market Cap
- YHGJ 14.0M
- NEPH 16.8M
- IPO Year
- YHGJ 1997
- NEPH 2004
- Fundamental
- Price
- YHGJ $0.60
- NEPH $1.56
- Analyst Decision
- YHGJ
- NEPH Buy
- Analyst Count
- YHGJ 0
- NEPH 1
- Target Price
- YHGJ N/A
- NEPH $5.00
- AVG Volume (30 Days)
- YHGJ 231.9K
- NEPH 9.2K
- Earning Date
- YHGJ 02-19-2025
- NEPH 03-06-2025
- Dividend Yield
- YHGJ N/A
- NEPH N/A
- EPS Growth
- YHGJ N/A
- NEPH N/A
- EPS
- YHGJ N/A
- NEPH N/A
- Revenue
- YHGJ $18,559,000.00
- NEPH $13,546,000.00
- Revenue This Year
- YHGJ N/A
- NEPH N/A
- Revenue Next Year
- YHGJ N/A
- NEPH $9.13
- P/E Ratio
- YHGJ N/A
- NEPH N/A
- Revenue Growth
- YHGJ 11.78
- NEPH 0.03
- 52 Week Low
- YHGJ $0.43
- NEPH $1.36
- 52 Week High
- YHGJ $1.85
- NEPH $3.76
- Technical
- Relative Strength Index (RSI)
- YHGJ 51.40
- NEPH 48.88
- Support Level
- YHGJ $0.52
- NEPH $1.51
- Resistance Level
- YHGJ $0.76
- NEPH $1.72
- Average True Range (ATR)
- YHGJ 0.11
- NEPH 0.07
- MACD
- YHGJ 0.01
- NEPH -0.00
- Stochastic Oscillator
- YHGJ 14.40
- NEPH 43.50
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.